6-Dehydro-6,17 alpha-dimethylprogesterone (NSC-123018) for the treatment of metastatic and recurrent ovarian carcinoma.
D000328:Adult; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D008524:Medrogestone / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D011245:Pregnadienes / Q000627:therapeutic use*; D011372:Progestins / Q000627:therapeutic use*
D011245:Pregnadienes; D011372:Progestins; D008524:Medrogestone